Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
IntroductionUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) characterized by mucosal damage and impaired epithelial barrier function. While glycyl-l-histidyl-l-lysine-copper (GHK-Cu) exhibits known anti-inflammatory properties, its therapeutic mechanisms in UC remain undefined....
Saved in:
| Main Authors: | Shuzhen Mao, Jiahui Huang, Junyan Li, Fang Sun, Qilian Zhang, Qing Cheng, Wei Zeng, Dongya Lei, Shiyan Wang, Jing Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1551843/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective
by: Seyedeh Maryam Mortazavi, et al.
Published: (2024-04-01) -
Exploring the health benefits of gut microbiota metabolites on combating ulcerative colitis via network pharmacology, bioinformatics and molecular docking
by: Weiguo Yao, et al.
Published: (2025-07-01) -
A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative Colitis
by: AlRasheed HA, et al.
Published: (2025-06-01) -
Exploration of JAK/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2/STAT3 in the inflammatory response
by: Cristina Calviño-Suárez, et al.
Published: (2025-07-01) -
Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
by: Ding-Jia-Cheng Jia, et al.
Published: (2022-12-01)